Article Sidebar

Download
pdf
Statistic
Read Counter : 18 Download : 20

Main Article Content

Abstract

Tingginya angka kematian akibat penyakit kardiovaskular (CVD) menjadi permasalahan kesehatan global yang serius. Data menunjukkan pada tahun 2019 terdapat 17,8 juta kematian akibat CVD dan diprediksi akan terus meningkat hingga 23 juta kasus pada tahun 2030. Faktor-faktor risiko CVD meliputi pola makan tidak sehat, stres oksidatif, dan inflamasi berkontribusi terhadap peningkatan risiko CVD. Tujuan penelitian ini adalah menganalisis peran likopen dalam menurunkan risiko penyakit CVD. Metode yang digunakan  dalam penelitian ini adalah literature review dengan mengumpulkan artikel ilmiah terkait dari berbagai database. Sebanyak 5 artikel yang relevan dan memenuhi kriteria inklusi digunakan dan dianalisis dalam penelitian ini. Hasil penelitian menunjukkan bahwa likopen memiliki sifat antioksidan kuat, sehingga mampu menekan stres oksidatif, dan meningkatkan aktivitas enzim antioksidan dalam tubuh. Selain itu, likopen juga memiliki efek antiinflamasi dengan kemampuannya dalam menghambat aktivitas sitokin proinflamasi dan menurunkan kolesterol total, trigliserida, LDL, serta meningkatkan kadar HDL. Likopen juga berperan dalam mengontrol tekanan darah yang juga merupakan faktor penting dalam pengelolaan risiko CVD. Berdasarkan mekanisme antioksidan, antiinflamasi, regulasi profil lipid dan tekanan darah, likopen memiliki peran signifikan dalam menurunkan risiko CVD. Mengonsumsi makanan yang kaya akan likopen dapat dijadikan sebagai upaya preventif terhadap pencegahan penyakit kardiovaskular.

Keywords

Antioksidan, likopen, penyakit kardiovaskular (CVD)

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish their manuscripts in this Journal agree to the following conditions:

  1. Copyright in each article belongs to author
  2. The author acknowledges that this journal has the right to publish articles with the copyright holder to author
  3. It is prohibited by law to copy or duplicate part or all of the contents of articles in this journal in any way and in any form and is prohibited from distributing the articles either electronically or printed without written permission from the Journal of Health, Education adn Literacy

References

  1. 1. Amini, M., Zayeri, F., & Salehi, M. (2021). Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health, 21(1), 1–12. https://doi.org/10.1186/s12889-021-10429-0
  2. 2. Bin-Jumah, M. N., Nadeem, M. S., Gilani, S. J., Mubeen, B., Ullah, I., Alzarea, S. I., Ghoneim, M. M., Alshehri, S., Al-Abbasi, F. A., & Kazmi, I. (2022). Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases. Antioxidants, 11(2), 1–21. https://doi.org/10.3390/antiox11020232
  3. 3. Deplanque, X., Muscente-Paque, D., & Chappuis, E. (2016). Proprietary tomato extract improves metabolic response to high-fat meal in healthy normal weight subjects. Food and Nutrition Research, 60, 1–8. https://doi.org/10.3402/fnr.v60.32537
  4. 4. Han, G. M., & Liu, P. (2017). Higher serum lycopene is associated with reduced prevalence of hypertension in overweight or obese adults. European Journal of Integrative Medicine, 13(February), 34–40. https://doi.org/10.1016/j.eujim.2017.07.002
  5. 5. Karimian, B., Soleimani, A., Mohammadsharifi, G., Heshmat-Ghahdarijani, K., Rejali, L., Shafie, D., Amerizadeh, A., & Sadeghi, M. (2022). Effect of Lycopene Supplementation on Some Cardiovascular Risk Factors and Markers of Endothelial Function in Iranian Patients with Ischemic Heart Failure: A Randomized Clinical Trial. Cardiology Research and Practice, 2022(Cvd). https://doi.org/10.1155/2022/2610145
  6. Kura, B., Parikh, M., Slezak, J., & Pierce, G. N. (2019). The influence of diet on microRNAs that impact cardiovascular disease. Molecules, 24(8), 1–16. https://doi.org/10.3390/molecules24081509
  7. 6. Li, D., Yang, S., Xing, Y., Pan, L., Zhao, R., Zhao, Y., Liu, L., & Wu, M. (2021). Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target. Frontiers in Cell and Developmental Biology, 9(July), 1–16. https://doi.org/10.3389/fcell.2021.673839
  8. 7. Martinez, V. P., Chiva-Blanch, G., Casas, R., Arranz, S., Martínez-Huélamo, M., Urpi-Sarda, M., Torrado, X., Corella, D., Lamuela-Raventós, R. M., & Estruch, R. (2016). Tomato sauce enriched with olive oil exerts greater effects on cardiovascular disease risk factors than raw tomato and tomato sauce: A randomized trial. Nutrients, 8(3), 1–14. https://doi.org/10.3390/nu8030170
  9. 8. Petyaev, I. M., Dovgalevsky, P. Y., Klochkov, V. A., Chalyk, N. E., Pristensky, D. V., Chernyshova, M. P., Udumyan, R., Kocharyan, T., Kyle, N. H., Lozbiakova, M. V., & Bashmakov, Y. K. (2018). Effect of lycopene supplementation on cardiovascular parameters and markers of inflammation and oxidation in patients with coronary vascular disease. Food Science and Nutrition, 6(6), 1770–1777. https://doi.org/10.1002/fsn3.734
  10. 9. Przybylska, S., & Tokarczyk, G. (2022). Lycopene in the Prevention of Cardiovascular Diseases. International Journal of Molecular Sciences, 23(4). https://doi.org/10.3390/ijms23041957
  11. 10. Rodrigues, J. ., Pinho, O., & Monteiro, P. R. R. (2018). Can lycopene be considered an effective protection against cardiovascular disease? Food Chemistry, 245(November 2017), 1148–1153. https://doi.org/10.1016/j.foodchem.2017.11.055
  12. 11. Senoner, T., & Dichtl, W. (2019). Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients, 11(9). https://doi.org/10.3390/nu11092090
  13. Tierney, A. C., Rumble, C. E., Billings, L. M., & George, E. S. (2020). Effect of Dietary and Supplemental Lycopene on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. Advances in Nutrition, 11(6), 1453–1488. https://doi.org/10.1093/advances/nmaa069
  14. 12. Valenzuela, C. A., Baker, E. J., Miles, E. A., & Calder, P. C. (2019). Eighteen‑carbon trans fatty acids and inflammation in the context of atherosclerosis. Progress in Lipid Research, 76(September), 101009. https://doi.org/10.1016/j.plipres.2019.101009
  15. 13. Wolak, T., Sharoni, Y., Levy, J., Linnewiel-Hermoni, K., Stepensky, D., & Paran, E. (2019). Effect of tomato nutrient complex on blood pressure: A double blind, randomized dose–response study. Nutrients, 11(5). https://doi.org/10.3390/nu11050950
  16. 14. Yanai, H., & Yoshida, H. (2019). Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: Mechanisms and perspectives. International Journal of Molecular Sciences, 20(5), 1–25. https://doi.org/10.3390/ijms20051190
  17. 15. Zhong, Q., Piao, Y. Y., Yin, S., & Zhang, K. Y. (2022). Association of serum lycopene concentrations with all-cause and cardiovascular mortality among individuals with chronic kidney disease: A cohort study. Frontiers in Nutrition, 9(December), 1–11. https://doi.org/10.3389/fnut.2022.1048884